User profiles for Hadi M. Yassine
 | HADI M. YASSINESection Head of Research, Associate Professor of Infectious Diseases, IBC chair, Qatar … Verified email at QU.edu.qa Cited by 17116 |
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
HM Yassine, JC Boyington, PM McTamney, CJ Wei… - Nature medicine, 2015 - nature.com
The antibody response to influenza is primarily focused on the head region of the hemagglutinin
(HA) glycoprotein, which in turn undergoes antigenic drift, thus necessitating annual …
(HA) glycoprotein, which in turn undergoes antigenic drift, thus necessitating annual …
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
Background Waning of vaccine protection against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The …
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The …
Effects of previous infection and vaccination on symptomatic omicron infections
Background The protection conferred by natural immunity, vaccination, and both against
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the …
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the …
Protection against the Omicron variant from previous SARS-CoV-2 infection
…, S AlMukdad, P Coyle, HM Yassine… - … England Journal of …, 2022 - Mass Medical Soc
Protection against Omicron by Previous SARS-CoV-2 Infection Using a national Covid-19
database in Qatar, investigators found that previous SARS-CoV-2 infection provided protection …
database in Qatar, investigators found that previous SARS-CoV-2 infection provided protection …
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar
Background Waning of vaccine protection against coronavirus disease 2019 (Covid-19)
and the emergence of the omicron (or B.1.1.529) variant of the severe acute respiratory …
and the emergence of the omicron (or B.1.1.529) variant of the severe acute respiratory …
Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2
…, S Younes, O Al-Jamal, HI Daas, HM Yassine… - Viruses, 2020 - mdpi.com
The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide
since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, …
since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, …
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar
The SARS-CoV-2 pandemic continues to be a global health concern. The mRNA-1273 (Moderna)
vaccine was reported to have an efficacy of 94.1% at preventing symptomatic COVID-…
vaccine was reported to have an efficacy of 94.1% at preventing symptomatic COVID-…
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar
SARS-CoV-2 Omicron BA.1 and BA.2 subvariants are genetically divergent. We conducted
a matched, test-negative, case-control study to estimate duration of protection of the second …
a matched, test-negative, case-control study to estimate duration of protection of the second …
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
M Kanekiyo, CJ Wei, HM Yassine, PM McTamney… - Nature, 2013 - nature.com
Influenza viruses pose a significant threat to the public and are a burden on global health
systems 1 , 2 . Each year, influenza vaccines must be rapidly produced to match circulating …
systems 1 , 2 . Each year, influenza vaccines must be rapidly produced to match circulating …
Pre-fusion structure of a human coronavirus spike protein
HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease 1 , and
is related to the zoonotic SARS 2 and MERS 3 betacoronaviruses, which have high fatality …
is related to the zoonotic SARS 2 and MERS 3 betacoronaviruses, which have high fatality …
